| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| |
Dependence on LSD and other hallucinogenic drugs |
Journal American Med... |
1967 |
| Goldenthal EI |
A compilation of LD50 values in newborn and adult animals |
Toxicol Appl Pharmac... |
1971 |
| Sreenivasan VR |
Problems in Identification of Methylenediony and Methoxy Amphetamines |
Journal of Criminal ... |
1972 |
| Rapp MS |
Reactions To Lysergide |
Lancet |
1974 |
| Shulgin AT, Helisten C |
Differentiation of PCP, TCP, and a contaminating precursor PCC, by thi... |
Microgram |
1975 |
| Murdock JE, Shulgin AT |
A novel illicit amphetamine laboratory |
Microgram |
1978 |
| Boublik JH, Quinn MJ, Cle... |
Coffee contains potent opiate receptor binding activity |
Nature |
1983 |
| McKenna DJ, Towers GH, Ab... |
Monoamine oxidase inhibitors in South American hallucinogenic plants: ... |
J Ethnopharmacol |
1984 |
| Greer G, Tolbert R |
Subjective reports of the effects of MDMA in a clinical setting |
J Psychoactive Drugs |
1986 |
| Holsten DW, Schieser DW |
Controls over the manufacture of MDMA |
J Psychoactive Drugs |
1986 |
| Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
| McCarron MM, Walberg CB, ... |
Confirmation of LSD intoxication by analysis of serum and urine |
J Anal Toxicol |
1990 |
| Kunsman GW, Manno JE, Coc... |
Application of the Syva EMIT and Abbott TDx amphetamine immunoassays t... |
J Anal Toxicol |
1990 |
| Verweij AM |
Clandestine manufacture of 3,4-methylenedioxymethylamphetamine (MDMA) ... |
Forensic Sci Int |
1990 |
| Barrett PJ |
'Ecstasy' misuse--overdose or normal dose? |
Anaesthesia |
1993 |
| Bohn M, Bohn G, Blaschke ... |
Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... |
Int J Legal Med |
1993 |
| O'Callaghan JP, Miller DB |
Quantification of reactive gliosis as an approach to neurotoxicity ass... |
NIDA Res Monogr |
1993 |
| Dal Cason TA |
The characterization of some 3,4-methylenedioxycathinone MDCATH homolo... |
Forensic Science Int... |
1997 |
| Holland JA, Nelson L, Rav... |
Embalming fluid-soaked marijuana: new high or new guise for PCP? |
J Psychoactive Drugs |
1998 |
| Sherlock K, Wolff K, Hay ... |
Analysis of illicit ecstasy tablets: implications for clinical managem... |
J Accid Emerg Med |
1999 |
| Chaudhry K |
Is pan masala-containing tobacco carcinogenic? |
Natl Med J India |
1999 |
| Liaudet L, Buclin T, Jacc... |
Drug points: severe ergotism associated with interaction between riton... |
BMJ |
1999 |
| Bell SEJ, Burns DT, Denni... |
Composition Profiling of Seized Ecstasy Tablets by Raman Spectroscopy ... |
Analyst |
2000 |
| Zhao H, Brenneisen R, Sch... |
Profiles of urine samples taken from Ecstasy users at Rave parties: an... |
J Anal Toxicol |
2001 |
| Pittler M, Edzard E |
Kava extract for treating anxiety (Cochrane Review) |
Cochrane Database Sy... |
2001 |
| Nichols DE |
LSD and Its Lysergamide Cousins |
Heffter Review |
2001 |
| Campo JV, McNabb J, Perel... |
Kava-induced fulminant hepatic failure |
J Am Acad Child Adol... |
2002 |
| Solomon PR, Adams F, Silv... |
Ginkgo for memory enhancement: a randomized controlled trial |
JAMA |
2002 |
| Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
| Cole JC, Bailey M, Sumnal... |
The content of ecstasy tablets: implications for the study of their lo... |
Addiction |
2002 |
| Chemic Labs |
Evaluation Of VolcanoŽ Vaporizer For The Efficient Emission Of THC, CB... |
MAPS.org |
2003 |
| Stout PR, Klette KL, Wieg... |
Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscre... |
J Anal Toxicol |
2003 |
| Mason L, Moore RA, Derry ... |
Systematic review of topical capsaicin for the treatment of chronic pa... |
BMJ |
2004 |
| Lachenmeier DW, Emmert J,... |
Thujone--cause of absinthism? |
Forensic Sci Int |
2006 |
| Padosch SA, Lachenmeier D... |
Absinthism: a fictitious 19th century syndrome with present impact |
Subst Abuse Treat Pr... |
2006 |
| Terry M, Steelman KL, Gui... |
Lower Pecos and Coahuila peyote: new radiocarbon dates |
J Archaelogical Scie... |
2006 |
| Schifano F, Deluca P, Bal... |
Drugs on the web; the Psychonaut 2002 EU project |
Prog Neuropsychophar... |
2006 |
| Kleber HD |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Foulds J, Furberg H |
Is low-nicotine Marlboro snus really snus? |
Harm Reduct J |
2008 |
| Lachenmeier DW, Nathan-Ma... |
Chemical composition of vintage preban absinthe with special reference... |
J Agric Food Chem |
2008 |
| Linde K, Berner MM, Krist... |
St John's wort for major depression |
Cochrane Database of... |
2008 |
| Schifanoa F, Corazzaa O, ... |
Psychoactive drug or mystical incense? Overview of the online availabl... |
International Journa... |
2009 |
| Brandt SD, Sumnall HR, Me... |
Analyses of second-generation 'legal highs' in the UK: Initial finding... |
Drug Test Anal |
2010 |
| Venkatratnam A, Lents NH |
Zinc reduces the detection of cocaine, methamphetamine, and THC by ELI... |
J Anal Toxicol |
2011 |
| Sumnall HR, Evans-Brown M... |
Social, policy, and public health perspectives on new psychoactive sub... |
Drug Test Anal |
2011 |
| Bowden M, Trevorrow P |
BZP and New Zealand's alternative approach to prohibition |
Drug Test Anal |
2011 |
| Bassindale T |
Benzylpiperazine: the New Zealand legal perspective |
Drug Test Anal |
2011 |
| Collins M |
Some new psychoactive substances: Precursor chemicals and synthesis-dr... |
Drug Test Anal |
2011 |
| Carroll FI, Lewin AH, Mas... |
Designer drugs: a medicinal chemistry perspective |
Ann N Y Acad Sci |
2011 |
| Carroll FI, Lewin AH, Mas... |
Designer drugs: a medicinal chemistry perspective |
Ann N Y Acad Sci |
2011 |
| Macher AM, Penders TM |
False-positive phencyclidine immunoassay results caused by 3,4-methyle... |
Drug Test Anal |
2012 |
| Johnson LA, Johnson RL, P... |
Current 'Legal Highs' |
J Emerg Med |
2013 |
| Spaderna M, Addy PH, D'So... |
Spicing things up: synthetic cannabinoids |
Psychopharmacology (... |
2013 |
| Patton AL, Seely KA, Pull... |
Quantitative Measurement of Acetyl Fentanyl and Acetyl Norfentanyl in ... |
Anal Chem |
2014 |
| Zamengo L, Frison G, Bett... |
Understanding the risks associated with the use of new psychoactive su... |
Toxicol Lett |
2014 |
| Barnett RY, Baker DD, Kel... |
A fatal intoxication of 2,5-dimethoxy-4-chloroamphetamine: a case repo... |
J Anal Toxicol |
2014 |
| Battal D, Barnes AJ, Cast... |
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantif... |
Ther Drug Monit |
2015 |
| Dasgupta N, Gilbert M |
Commentary van der Gouwe et al(2017): Drug-testing services and crypto... |
Addiction |
2017 |
| Misailidi N, Papoutsis I,... |
Furanylfentanyl: another fentanyl analogue, another hazard for public ... |
Forensic Toxicol |
2017 |
| Elliott L, Benoit E, Camp... |
The long tail of a demon drug: The 'bath salts' risk environment |
Int J Drug Policy |
2017 |
| Krieger MS, Yedinak JL, B... |
High willingness to use rapid fentanyl test strips among young adults ... |
Harm Reduct J |
2018 |
| Kavanaugh PR, Biggers Z |
Competing constructions of bath salts use and risk of harm in two medi... |
Crime Media Culture |
2018 |
| Krieger MS, Goedel WC, Bu... |
Use of rapid fentanyl test strips among young adults who use drugs |
Int J Drug Policy |
2018 |
| Peiper NC, Clarke SD, Vin... |
Fentanyl test strips as an opioid overdose prevention strategy: Findin... |
Int J Drug Policy |
2019 |
| Goldman JE, Waye KM, Peri... |
Perspectives on rapid fentanyl test strips as a harm reduction practic... |
Harm Reduction Journ... |
2019 |
| Vandeputte MM, Krotulski ... |
Phenethyl-4-ANPP: a Marginally Active Byproduct Suggesting a Switch in... |
J Anal Toxicol |
2021 |
